5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide

C85H71F5N30O5 — CID 160624718

IUPAC5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide
SMILESCC(=O)Nc1cn[nH]c1-c1nc2ccccc2[nH]1.Nc1cn[nH]c1-c1nc2ccccc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)C(F)(F)F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)C1CCCCC1.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1ccccc1
InChIInChI=1S/C17H11F2N5O.C17H19N5O.C17H13N5O.C12H8F3N5O.C12H11N5O.C10H9N5/c18-9-4-3-5-10(19)14(9)17(25)23-13-8-20-24-15(13)16-21-11-6-1-2-7-12(11)22-16;2*23-17(11-6-2-1-3-7-11)21-14-10-18-22-15(14)16-19-12-8-4-5-9-13(12)20-16;13-12(14,15)11(21)19-8-5-16-20-9(8)10-17-6-3-1-2-4-7(6)18-10;1-7(18)14-10-6-13-17-11(10)12-15-8-4-2-3-5-9(8)16-12;11-6-5-12-15-9(6)10-13-7-3-1-2-4-8(7)14-10/h1-8H,(H,20,24)(H,21,22)(H,23,25);4-5,8-11H,1-3,6-7H2,(H,18,22)(H,19,20)(H,21,23);1-10H,(H,18,22)(H,19,20)(H,21,23);1-5H,(H,16,20)(H,17,18)(H,19,21);2-6H,1H3,(H,13,17)(H,14,18)(H,15,16);1-5H,11H2,(H,12,15)(H,13,14)
InChIKeyRHDLXICZBWCUGY-UHFFFAOYSA-N
MW1687.70 g/mol
LogP16.06
Rot. Bonds14

About 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide

5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide (PubChem CID 160624718) has the molecular formula C85H71F5N30O5 and a molecular weight of 1687.70 g/mol. Its IUPAC name is 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide.

Molecular Properties

Compound Name5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide
PubChem CID160624718
Molecular FormulaC85H71F5N30O5
Molecular Weight1687.70 g/mol
Exact Mass1686.61
IUPAC Name5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide
SMILESCC(=O)Nc1cn[nH]c1-c1nc2ccccc2[nH]1.Nc1cn[nH]c1-c1nc2ccccc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)C(F)(F)F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)C1CCCCC1.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1ccccc1
InChIInChI=1S/C17H11F2N5O.C17H19N5O.C17H13N5O.C12H8F3N5O.C12H11N5O.C10H9N5/c18-9-4-3-5-10(19)14(9)17(25)23-13-8-20-24-15(13)16-21-11-6-1-2-7-12(11)22-16;2*23-17(11-6-2-1-3-7-11)21-14-10-18-22-15(14)16-19-12-8-4-5-9-13(12)20-16;13-12(14,15)11(21)19-8-5-16-20-9(8)10-17-6-3-1-2-4-7(6)18-10;1-7(18)14-10-6-13-17-11(10)12-15-8-4-2-3-5-9(8)16-12;11-6-5-12-15-9(6)10-13-7-3-1-2-4-8(7)14-10/h1-8H,(H,20,24)(H,21,22)(H,23,25);4-5,8-11H,1-3,6-7H2,(H,18,22)(H,19,20)(H,21,23);1-10H,(H,18,22)(H,19,20)(H,21,23);1-5H,(H,16,20)(H,17,18)(H,19,21);2-6H,1H3,(H,13,17)(H,14,18)(H,15,16);1-5H,11H2,(H,12,15)(H,13,14)
InChIKeyRHDLXICZBWCUGY-UHFFFAOYSA-N
XLogP16.06
TPSA515.68 Ų
H-Bond Donors18
H-Bond Acceptors18
Rotatable Bonds14
Heavy Atoms125
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001687.70
LogP ≤ 516.06
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1018

Analyze 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(3-(1H-Benzimidazol-2-yl)-1H-pyrazol-4-yl)benzamide
CID 135566361
N-[3-(1H-benzimidazol-2-yl)-1-methylpyrazol-4-yl]-2-fluorobenzamide
CID 136239321
N-[2-cyclohexyl-6-[2-[3-[[2-cyclohexyl-6-(diethylamino)-3H-benzimidazol-5-yl]carbamoyl]-5-fluorophenyl]ethyl-ethylamino]-3H-benzimidazol-5-yl]pyridazine-4-carboxamide
CID 123782723
N-[6-[2-[3-[[6-(diethylamino)-2-heptan-4-yl-3H-benzimidazol-5-yl]carbamoyl]-5-fluorophenyl]ethyl-ethylamino]-2-heptan-4-yl-3H-benzimidazol-5-yl]pyridazine-4-carboxamide
CID 123928240
N-[3-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluoro-benzamide
CID 135458177
N-[3-(5-dimethylaminomethyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluoro-benzamide
CID 136073234
2,6-difluoro-N-[5-(5-fluoro-4-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide
CID 136073237
2,6-difluoro-N-[5-[6-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
CID 136073254
2-[4-(2,6-difluoro-benzoylamino)-1H-pyrazol-3-yl]-1H-benzimidazole-5-carboxylic acid amide
CID 136073259
2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-N,N-dimethyl-3H-benzimidazole-5-carboxamide
CID 136073261
2,6-difluoro-N-[5-[6-[(4-methylpiperidin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
CID 136073268
N-[5-(5,6-difluoro-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide
CID 136073285

Frequently Asked Questions

What is the IUPAC name of 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide?
The IUPAC name of 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide (CID 160624718) is 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide.
What is the SMILES notation for 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide?
The canonical SMILES for 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide is CC(=O)Nc1cn[nH]c1-c1nc2ccccc2[nH]1.Nc1cn[nH]c1-c1nc2ccccc2[nH]1.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)C(F)(F)F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)C1CCCCC1.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1ccccc1.
What is the InChIKey of 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide?
The InChIKey is RHDLXICZBWCUGY-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H11F2N5O.C17H19N5O.C17H13N5O.C12H8F3N5O.C12H11N5O.C10H9N5/c18-9-4-3-5-10(19)14(9)17(25)23-13-8-20-24-15(13)16-21-11-6-1-2-7-12(11)22-16;2*23-17(11-6-2-1-3-7-11)21-14-10-18-22-15(14)16-19-12-8-4-5-9-13(12)20-16;13-12(14,15)11(21)19-8-5-16-20-9(8)10-17-6-3-1-2-4-7(6)18-10;1-7(18)14-10-6-13-17-11(10)12-15-8-4-2-3-5-9(8)16-12;11-6-5-12-15-9(6)10-13-7-3-1-2-4-8(7)14-10/h1-8H,(H,20,24)(H,21,22)(H,23,25);4-5,8-11H,1-3,6-7H2,(H,18,22)(H,19,20)(H,21,23);1-10H,(H,18,22)(H,19,20)(H,21,23);1-5H,(H,16,20)(H,17,18)(H,19,21);2-6H,1H3,(H,13,17)(H,14,18)(H,15,16);1-5H,11H2,(H,12,15)(H,13,14).
What are the key properties of 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide?
5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide has a molecular weight of 1687.70 g/mol, XLogP of 16.06, 14 rotatable bonds, 18 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-amine;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]acetamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]benzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]cyclohexanecarboxamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-difluorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,2,2-trifluoroacetamide is sourced from PubChem (CID 160624718), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).